Jagsonpal Pharmaceuticals

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue54.4743.6260.6060.5360.14
Expenses49.2344.4157.0747.8351.84
EBITDA5.24-0.793.5312.708.30
EBIT4.87-1.443.3412.507.97
Profit Before Tax7.14-0.483.8313.799.87
Net Profit5.41-0.712.9210.417.78
Financial Ratios
Operating Profit Margin9.62%-1.79%5.83%20.98%13.80%
Net Profit Margin9.93%-1.63%4.82%17.20%12.94%
Earning Per Share (Diluted)2.06-0.272.133.972.97
Dividends Per ShareNA4.00NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI